Department of Anesthesia, Surgery, Physiology and Pathology, University of Manitoba, St. Boniface Hospital, Winnipeg, Canada.
Can J Physiol Pharmacol. 2012 Sep;90(9):1287-93. doi: 10.1139/y2012-026. Epub 2012 May 30.
Brain death (BD) causes cardiac dysfunction in organ donors, attributable to the catecholamine storm that occurs with raised intracerebral pressure (ICP). However the direct contribution of the spinal sympathetics has not been well described. We examined the effect of total spinal anesthesia (TSA) on cardiac function in a large animal model of BD. Eighteen pigs were allocated to 3 experimental groups: Group 1, the saline-treated control group; Group 2, TSA administered prior to BD; and Group 3, TSA administered 30 min after BD. Inflation of an intracerebral balloon-tipped catheter was used to induce BD. Ventricular function was assessed using a pressure-volume loop catheter and magnetic resonance imaging. Serum catecholamine levels were assessed with high performance liquid chromatography. Inflation of the intracerebral balloon-tipped catheter was associated with a dramatic rise in heart rate and blood pressure, along with increased concentrations of serum epinephrine and norepinephrine. This phenomenon was not observed in Group 2. In Group 1, there was a significant decline in contractility, whereas groups 2 and 3 saw no change. Group 2 had greater contractile reserve than groups 1 and 3. Our data demonstrate the central role of spinal sympathetics in the hemodynamic response to raised ICP. Further work is required to determine the utility of TSA in reversing cardiac dysfunction in BD donors.
脑死亡(BD)导致器官捐献者心脏功能障碍,这归因于颅内压升高时发生的儿茶酚胺风暴。然而,脊髓交感神经的直接作用尚未得到很好的描述。我们在 BD 的大型动物模型中研究了全身麻醉(TSA)对心脏功能的影响。将 18 头猪分配到 3 个实验组:第 1 组,生理盐水处理的对照组;第 2 组,BD 前给予 TSA;第 3 组,BD 后 30 分钟给予 TSA。使用颅内球囊尖端导管充气来诱导 BD。使用压力-容积环导管和磁共振成像评估心室功能。使用高效液相色谱法评估血清儿茶酚胺水平。颅内球囊尖端导管的充气与心率和血压的急剧升高有关,同时血清肾上腺素和去甲肾上腺素的浓度增加。第 2 组未观察到这种现象。第 1 组的收缩性显著下降,而第 2 组和第 3 组没有变化。第 2 组的收缩性储备大于第 1 组和第 3 组。我们的数据表明,脊髓交感神经在颅内压升高引起的血流动力学反应中起着核心作用。需要进一步研究以确定 TSA 在逆转 BD 供体心脏功能障碍中的效用。